Pharmaceutical & Drug Manufacturers Pharmaceutical & Drug Manufacturers Pharmaceutical & Drug Manufacturers
BUSINESS DIRECTORY PRODUCT CATALOG PHARMACEUTICAL CATALOGS PHARMA TRADE LEADS EXPORT IMPORT POLICIES POLICIES & ORDERS

Home » Pharmaceutical Drugs » Pharmaceutical Finished Formulations » Tablets »

Finished Formulations
Pharmaceutical Drugs

Glossary



HYOSINE BUTYL BROMIDE


The drug has a special site of action at the parasympathetic ganglia in the walls of the viscera, which exerts a specific antispasmodic action on the smooth muscle of the gastrointestinal, billary and urinary tracts.

Iupac Name: [7(S)-(1a , -2§, 4§,5a , 7§)]-9-butyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl -3-oxa-9-azoniatricyclo [3.3.1.0 2,4] nonane bromide.

Dosage
10 - 20 mg 3-5 times daily. i.m. or i.v. 20-40 mg 3- 5 times daily

Contra- Indications: Gluacoma, retention of urine. Mechanical stenoses in the region of G.I.T. Tachycardia, megacolon.

Side Effects
The drug has certain side effects, that can affect individuals in different ways. The following are some of the side effects, that are often associated with the drug:
  • Increased pulse rate
  • Vision disturbances due to i.v. Administration.
There is no evidence of risk for lactating women.

Disclaimer: The above information is for general understanding of the visitor. Please consult a registered medical practitioner before taking the aforesaid medicine.